Evidence map›Paper›PMID 38412527›Full record

ArticleMicrobiology spectrum2024

Earliest observation of the tetracycline destructase

Frédéric Grenier, Simon Lévesque, Sébastien Rodrigue, Louis-Patrick Haraoui

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Global emergence ofMicrobial genomics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Frédéric GrenierDepartment of Biology, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Simon LévesqueDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Sébastien RodrigueDepartment of Biology, Université de Sherbrooke, Sherbrooke, Québec, Canada.ORCID 0000-0002-5366-7234
Louis-Patrick HaraouiDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.ORCID 0000-0002-3713-7866

Funding

Canadian Institute for Advanced Research (ICRA) GS-0000000256FRQ | Fonds de Recherche du Québec - Santé (FRQS) 282182New Frontiers in Research Fund NFRFE-2019-00444
6 · The paper itself

Abstract

Tigecycline is an antibiotic of last resort for infections with carbapenem-resistant IMPORTANCE: We present the earliest observation of a

Indexed as

Anti-Bacterial AgentsTetracyclineCarbapenemsMicrobial Sensitivity TestsPlasmidsTigecyclineAnti-Bacterial AgentsCarbapenemsTetracyclineTigecyclineAcinetobacter juniiantimicrobial resistanceblaOXA-58Israeltetracycline destructasetet(X3)

Identifiers

PMID38412527
PMCPMC10986324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.